MIDDLE EAST AND AFRICA BIOSURGERY MARKET 2019-2027

MARKET OUTLOOK
The biosurgery market in the Middle East & Africa has been projected to depict growth in terms of revenue and expand with a CAGR of 9.40% during the forecast years 2019-2027, according to a research conducted by Triton.
Saudi Arabia, Turkey, the UAE, South Africa and the countries in rest of MEA have been considered for analysis in the report on the biosurgery market in the Middle East & Africa region.
Governments of different nations are constantly enhancing their healthcare policies related to reimbursement and compensation. This is likely to create new opportunities for the healthcare payers and players. The high reimbursement rate is likely to drive the market for surgeries, thus creating opportunity for growing the biosurgery market. Orthopedic surgery has experienced much technological advancement over the years; and in this advancement, orthobiologics and bone grafting play a significant role. The rising number of bone disorders are likely to create the opportunity for biosurgeries. Furthermore, there is an increase in investment for the development of hybrid material in bone grafting, which is likely to create more advanced opportunities for the biomaterial and cell-based research and also for the approaches used to enhance bone regeneration. Thus, increasing investments in the development of hybrid material for bone grafting are creating opportunities for the growth of the biosurgery market.
Vendors find it challenging to remain competitive in the market because of the lack of significant differentiation in the range of products. Since most features and functionalities of products are similar in nature, a majority of the end-users tend to make selections based on their familiarity with a specific brand name. Thus, it is critical for the manufacturers to develop a technologically advanced product line for future growth.
COMPETITIVE OUTLOOK
The preeminent companies in the biosurgery market are Johnson & Johnson, B. Braun Melsungen AG, Smith & Nephew Plc, Sanofi, Zimmer Biomet Holdings, Inc., Medtronic Plc, Olympus Corporation, Ypsomed Holding AG, Baxter International, Inc., Stryker Corporation, RTI Surgical, Ethicon, Inc. and Wright Medical Group N.V.

TABLE OF CONTENTS
1. BIOSURGERY MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. TRENDS IN BIOSURGERY TECHNOLOGY
2.3. REGULATORY FRAMEWORK
2.4. KEY VENDORS OUTLOOK
2.5. KEY INSIGHTS
2.6. KEY BUYING OUTLOOK
2.7. KEY PATENT OUTLOOK
2.8. MARKET DRIVERS
2.8.1. RISE IN SURGICAL TREATMENTS FOR MUSCULOSKELETAL DISORDERS
2.8.2. RISE IN SPINAL FUSION AND JOINT RECONSTRUCTION
2.8.3. INCREASING TRAUMA-RELATED WOUNDS
2.9. MARKET RESTRAINTS
2.9.1. STRINGENT REGULATORY APPROVAL
2.9.2. INCREASE IN THE COST OF SURGERIES
2.9.3. INCREASING USAGE OF MINIMALLY INVASIVE SURGERIES
2.9.4. LACK OF AWARENESS
2.10. MARKET OPPORTUNITIES
2.10.1. DEVELOPMENT OF POLICY FOR REIMBURSEMENT AND COMPENSATION
2.10.2. INCREASE IN RESEARCH AND INVESTMENT IN BIOENGINEERING
2.11. MARKET CHALLENGES
2.11.1. AMPLIFIED SCRUTINY OF STEM CELL-DERIVED PRODUCTS
2.11.2. COMPLICATION RELATED TO IMMUNE RESPONSE
2.11.3. LACK OF SIGNIFICANT DIFFERENTIATION IN THE RANGE OF PRODUCTS
2.11.4. PRODUCT SIDE-EFFECTS AND FDA INQUIRY
3. BIOSURGERY MARKET OUTLOOK - BY PRODUCT
3.1. BONE GRAFT SUBSTITUTES
3.1.1. SYNTHETIC GRAFT EXTENDER
3.1.2. DEMINERALIZED BONE MATRIX
3.1.3. BONE MORPHOGENETIC PROTEINS
3.1.4. CELL-BASED MATRICES
3.2. HEMOSTATIC AGENTS
3.3. SOFT TISSUE MANAGEMENT
3.3.1. SYNTHETIC MESH/PATCH
3.3.2. NATURAL MESH/PATCH
3.4. SURGICAL SEALING AGENTS
3.4.1. NATURAL SURGICAL SEALING AGENTS
3.4.2. SYNTHETIC SURGICAL SEALING AGENTS
3.5. ANTI-ADHESIVE AGENTS
4. BIOSURGERY MARKET OUTLOOK - BY APPLICATION
4.1. NEURO AND SPINE SURGERY
4.2. CARDIO AND THORACIC SURGERY
4.3. GENERAL SURGERY
4.4. ORTHOPEDIC SURGERY
5. BIOSURGERY MARKET OUTLOOK - BY SOURCE TYPE
5.1. NATURAL
5.2. SYNTHETIC
6. BIOSURGERY MARKET - REGIONAL OUTLOOK
6.1. MIDDLE EAST AND AFRICA
6.1.1. COUNTRY ANALYSIS
6.1.1.1. SAUDI ARABIA
6.1.1.2. TURKEY
6.1.1.3. UNITED ARAB EMIRATES
6.1.1.4. SOUTH AFRICA
6.1.1.5. REST OF MIDDLE EAST AND AFRICA
7. COMPETITIVE LANDSCAPE
7.1. B. BRAUN MELSUNGEN AG
7.2. JOHNSON & JOHNSON
7.3. BAXTER INTERNATIONAL, INC.
7.4. ETHICON, INC.
7.5. MEDTRONIC PLC
7.6. SANOFI
7.7. OLYMPUS CORPORATION
7.8. RTI SURGICAL
7.9. SMITH & NEPHEW PLC
7.10. STRYKER CORPORATION
7.11. ZIMMER BIOMET HOLDINGS, INC.
7.12. WRIGHT MEDICAL GROUP N.V.
7.13. YPSOMED HOLDING AG
8. METHODOLOGY AND SCOPE
8.1. RESEARCH SCOPE
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY




TABLE LIST
TABLE 1 MIDDLE EAST AND AFRICA BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
TABLE 2 MEDICAL DEVICE CLASSIFICATION
TABLE 3 TYPES OF PMA SUPPLEMENTS
TABLE 4 MEDICAL DEVICES BY CLASS
TABLE 5 MIDDLE EAST AND AFRICA BIOSURGERY MARKET BY PRODUCTS 2019-2027 (IN $ MILLION)
TABLE 6 DIFFERENT TYPES OF BONE GRAFT SUBSTITUTES
TABLE 7 KEY OSTEOBIOLOGIC PRODUCTS AVAILABLE IN THE MARKET
TABLE 8 KEY SOFT TISSUE MANAGEMENT PRODUCTS AVAILABLE IN THE MARKET
TABLE 9 MIDDLE EAST AND AFRICA BIOSURGERY MARKET IN SOFT TISSUE MANAGEMENT BY TYPES 2019-2027 (IN $ MILLION)
TABLE 10 KEY SURGICAL SEALING AGENTS AVAILABLE IN THE MARKET
TABLE 11 MIDDLE EAST AND AFRICA BIOSURGERY MARKET IN SURGICAL SEALING AGENTS BY TYPES 2019-2027 (IN $ MILLION)
TABLE 12 MIDDLE EAST AND AFRICA BIOSURGERY MARKET BY APPLICATIONS 2019-2027 (IN $ MILLION)
TABLE 13 TYPES OF CARDIOVASCULAR DISEASES
TABLE 14 STAGES OF GRAFT HEALING AND THEIR CHARACTERISTICS
TABLE 15 MIDDLE EAST AND AFRICA BIOSURGERY MARKET BY SOURCE TYPE 2019-2027 (IN $ MILLION)
TABLE 16 MIDDLE EAST AND AFRICA BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)




FIGURES LIST
FIGURE 1 MIDDLE EAST AND AFRICA BIOSURGERY MARKET 2019-2027 (IN $ MILLION)
FIGURE 2 KEY STRATEGIES IN BIOSURGERY MARKET
FIGURE 3 DIFFERENT TYPES OF NATURAL BIOSURGICAL SEALANTS
FIGURE 4 MIDDLE EAST AND AFRICA BIOSURGERY MARKET BY BONE GRAFT SUBSTITUTES 2019-2027 (IN $ MILLION)
FIGURE 5 MIDDLE EAST AND AFRICA BONE GRAFT SUBSTITUTES MARKET BY SYNTHETIC GRAFT EXTENDERS 2019-2027 (IN $ MILLION)
FIGURE 6 MIDDLE EAST AND AFRICA BONE GRAFT SUBSTITUTES MARKET BY DEMINERALIZED BONE MATRIX 2019-2027 (IN $ MILLION)
FIGURE 7 MIDDLE EAST AND AFRICA BONE GRAFT SUBSTITUTES MARKET BY BONE MORPHOGENETIC PROTEINS 2019-2027 (IN $ MILLION)
FIGURE 8 MIDDLE EAST AND AFRICA BONE GRAFT SUBSTITUTES MARKET BY CELL-BASED MATRICES 2019-2027 (IN $ MILLION)
FIGURE 9 MIDDLE EAST AND AFRICA BIOSURGERY MARKET BY HEMOSTATIC AGENTS 2019-2027 (IN $ MILLION)
FIGURE 10 MIDDLE EAST AND AFRICA BIOSURGERY MARKET BY SOFT TISSUE MANAGEMENT 2019-2027 (IN $ MILLION)
FIGURE 11 MIDDLE EAST AND AFRICA BIOSURGERY MARKET IN SOFT TISSUE MANAGEMENT 2019-2027 (IN $ MILLION)
FIGURE 12 MIDDLE EAST AND AFRICA SOFT TISSUE MANAGEMENT MARKET BY SYNTHETIC MESHES 2019-2027 (IN $ MILLION)
FIGURE 13 MIDDLE EAST AND AFRICA BIOSURGERY MARKET BY SURGICAL SEALING AGENTS 2019-2027 (IN $ MILLION)
FIGURE 14 MIDDLE EAST AND AFRICA SURGICAL SEALING AGENTS MARKET BY NATURAL 2019-2027 (IN $ MILLION)
FIGURE 15 MIDDLE EAST AND AFRICA SURGICAL SEALING AGENTS MARKET BY SYNTHETIC 2019-2027 (IN $ MILLION)
FIGURE 16 MIDDLE EAST AND AFRICA BIOSURGERY MARKET IN ANTI-ADHESIVE AGENTS 2019-2027 (IN $ MILLION)
FIGURE 17 MIDDLE EAST AND AFRICA BIOSURGERY MARKET BY NEURO AND SPINE SURGERY 2019-2027 (IN $ MILLION)
FIGURE 18 MIDDLE EAST AND AFRICA BIOSURGERY MARKET BY CARDIO AND THORACIC SURGERY 2019-2027 (IN $ MILLION)
FIGURE 19 MIDDLE EAST AND AFRICA BIOSURGERY MARKET BY GENERAL SURGERY 2019-2027 (IN $ MILLION)
FIGURE 20 MIDDLE EAST AND AFRICA BIOSURGERY MARKET BY ORTHOPEDIC SURGERY 2019-2027 (IN $ MILLION)
FIGURE 21 MIDDLE EAST AND AFRICA BIOSURGERY MARKET BY NATURAL 2019-2027 (IN $ MILLION)
FIGURE 22 MIDDLE EAST AND AFRICA BIOSURGERY MARKET BY SYNTHETIC 2019-2027 (IN $ MILLION)
FIGURE 23 SAUDI ARABIA BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)
FIGURE 24 TURKEY BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)
FIGURE 25 UNITED ARAB EMIRATES BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)
FIGURE 26 SOUTH AFRICA BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)
FIGURE 27 REST OF MIDDLE EAST AND AFRICA BIOSURGERY MARKET 2019-2027 (IN $ MILLION)